간세포암종에서 편평세포 성장인자와 c-ErbB-2의 발현 부재
Rarity of EGFR and c-ErbB-2 Overexpressions in Hepatocellular Carcinoma: An Immunohistochemical Study
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : The overexpression of epidermal growth factor receptor (EGFR) and c-erbB- 2 oncogenes has been implicated in the development of many types of cancer. However, the role of EGFR and c-erbB-2 overexpression in hepatocellular carcinoma (HCC) has not been fully elucidated. Methods : The aim of this study was to evaluate the immunohistochemical expression of EGFR and c-erbB-2 oncoprotein in a series of 52 HCCs. Results : All but one of the HCC tumor tissues were negative for EGFR monoclonal antibody, clone H11. All of the HCC tumor tissue samples were negative for EGFR monoclonal antibody, clone 29.1.1. However, strong EGFR immunoreactivity was detected in sinusoidal endothelial cells of HCC in 25 tumors (48%) using EGFR 29.1.1 antibody. The expression of c-erbB-2 was observed in 6% (3/52) of the HCCs. No significant correlation was found between p53 mutation and the expression of c-erbB-2. Conclusion : Our results suggest that both EGFR and c-erbB-2 oncoprotein overexpressions in tumor cells are rare and do not seem to predominantly contribute to the malignant phenotype in HCC.
참고문헌 (24)
- "Type 1 (EGFR-related) family of growth fac-tor receptors and their ligands.", pp.1~1 24
- "Epider-mal growth factor-related peptides and their relevance to gastroin-testinal pathophysiology", 108, pp.564~580 (1995)
- "c-erbB-2 in HCC 247", pp.281~302
- "HER-2", neu (c-erbB2) gene and protein in breastcancer, 1999, pp.112, 53~67
- "Expressionof the type I tyrosine kinase growth factor receptors: EGFreceptor,c-erbB-2 and c-erbB-3 in bladder cancer", 179, pp.381~385 (1996)
- "Expression of HER-2", neuoncoprotein and epidermal growth factor receptor and prognosisin gastric carcinoma, 235~9
- "Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer", 101, pp.390~394 (2002)
- "Epidermal growth factor receptor-targetedtherapy in colorectal cancer", pp.10~7
- "The future of targeted therapy:combining novel agents.", 63, pp.47~56 (2002)
- "Why the epidermal growth factor receptor? The rationalefor cancer therapy.", 7, pp.2~8 (2002)
- "Expression and clinical significanceof erb-B receptor family in hepatocellular carcinoma", 18, pp.1377~1383 (2001)
- "C-erb-B-2 oncoprotein and epidermal growth factor receptor in humanhepatocellular carcinoma: an immunohistochemical study.", pp.677~82
- "HER-2", neu overexpression is rare in hepatocellular and not predictive ofanti-HER-2, pp.2002, 94[DOI]
- "Oncogenicexpression in cholangiocarcinoma and in normal hepatic development", pp.1163~8
- "Expression of transforming growth factor alpha and epidermalgrowth factor receptor in human hepatocellular carcinoma", 17, pp.177~182 (1997)
- "p53: the ultimate tumor suppressor gene?", pp.3169~3176 (1992)
- "Wild-type p53 can downmodulatethe activity of various promoters", 88, pp.9979~9983 (1991)
- "A comparison of the biological activitiesof wild type and mutant p53", 7, pp.855~865 (1993)
- "Absence of therapeutically relevant c-erbB-2 expression in human hepatocellular carcinoma", pp.727~730 (2001)
- "C-erbB-2 oncogene expression inhepatocellular carcinoma and cholangiocarcinoma.", pp.377~380 (1992)
- "Interrelationshipof results from immunohistochemical and biochemicaldeterminations of HER-2", neu oncoprotein in breast cancer, 1991, pp.96, ~
- "Immunohistochemicaldetection of the neu protein in tissue sections of humanbreast tumors with amplified neu DNA", 2, pp.175~178 (1988)
- "Spatiotemporalexpression of angiogenesis growth factor receptors during therevascularization of regenerating rat liver", 34, pp.1135~1148 (2001)
- "Epidermalgrowth factor receptor in meningiomas is expressed predominantlyon endothelial cells", pp.2139~2144 (1988)